Home›Stock Screener›Sudeep Pharma›Financial Statements

Sudeep Pharma Complete Financial Statements

5 Years of Data
2025 - 2020

In FY2025, Sudeep Pharma (SUDEEPPHRM) reported revenue ₹173 Cr, net profit ₹47 Cr and EPS ₹4.20, with a net profit margin of 27.2% and ROE of 9.5%. Full financial statements from FY2020 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore SUDEEPPHRM value investing to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 27.17% 2025 data
EBITDA Margin 38.15% 2025 data
Operating Margin 34.00% 2025 data
Return on Assets 6.56% 2025 data
Return on Equity 9.53% 2025 data

Balance Sheet Ratios

Current Ratio 8.65 2025 data
Equity Ratio 68.76% 2025 data
Asset Turnover 0.24 2025 data

SUDEEPPHRM Revenue, Net Profit & EBITDA — Year-on-Year Growth

SUDEEPPHRM YoY (Sept 2024 vs Sept 2025) — revenue +14.6%, net profit -4.1%, EBITDA +1.5%, expenses +25.9%. For live price, earnings ratios and company overview, see Sudeep Pharma screener.

Revenue Growth
+14.6%
Year-over-Year
Net Profit Growth
-4.1%
Year-over-Year
EBITDA Growth
+1.5%
Year-over-Year
Expense Growth
+25.9%
Year-over-Year
Assets Growth
+39.5%
Year-over-Year
Equity Growth
+38.5%
Year-over-Year
Operating Cash Flow Growth
-25.8%
Year-over-Year
Investing Cash Flow Growth
-61.2%
Year-over-Year
Financing Cash Flow Growth
+507.7%
Year-over-Year

SUDEEPPHRM Income Statement — Revenue, EBITDA & Net Profit

Sudeep Pharma revenue ₹173 Cr, EBITDA ₹66 Cr, net profit ₹47 Cr, EPS ₹4.20 (2025) — net profit margin 27.2%. Review Sudeep Pharma P/E valuation to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Jun 2024 Dec 2024
Revenue 173 161 130 179 151 81 118
Expenses 107 99 81 112 85 52 76
EBITDA 66 63 49 67 65 30 42
Operating Profit Margin % 34.00% 37.00% 35.00% 35.00% 43.00% 35.00% 34.00%
Depreciation 4 3 3 4 3 3 3
Interest 2 2 2 1 1 2 1
Profit Before Tax 60 58 44 62 62 26 38
Tax 13 14 13 14 13 9 9
Net Profit 47 44 31 48 49 17 29
Earnings Per Share (₹) 4.20 4.54 2.84 4.29 4.49 4.49 2.65

SUDEEPPHRM Balance Sheet — Assets, Liabilities & Shareholders' Equity

SUDEEPPHRM total assets ₹717 Cr, total equity ₹493 Cr, total liabilities ₹ Cr (2025) — ROE 9.5%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2022 2021 2020
ASSETS
Total Assets 717 514 344 213 131
Current Assets 424 275 197 100 56
Fixed Assets 189 180 137 68 60
Capital Work in Progress 88 45 8 24 8
Investments 0 0 0 0 0
Other Assets 440 289 199 121 63
LIABILITIES
Total Liabilities
Current Liabilities 49 21 34 19 13
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 493 356 163 114 81
Share Capital 12 1 1 1 1
Reserves & Surplus 481 355 162 113 80

SUDEEPPHRM Cash Flow Statement — Operating, Investing & Financing

Sudeep Pharma operating cash flow ₹49 Cr, investing ₹-79 Cr, financing ₹53 Cr, net cash flow ₹23 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2022 March 2021 March 2020
Operating Activities 49 66 -3 35 10
Investing Activities -79 -49 -38 -40 -23
Financing Activities 53 -13 51 13 12
Net Cash Flow 23 4 10 8 0